These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14518276)

  • 41. [Significance of allopeptide-induced expression of Fas ligand (FasL) in parenchyma of allogenic heart transplants as the cause of donor-specific tolerance induction].
    Dresske B; Schröder J; Zavazava N; Kremer B; Fändrich F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):83-7. PubMed ID: 14518218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
    Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
    J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of alloreactive T suppressor cells in the maintenance phase of spontaneous tolerance after orthotopic liver transplantation in the rat.
    Knoop M; Pratt JR; Hutchinson IV
    Transplantation; 1994 May; 57(10):1512-5. PubMed ID: 8197616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apoptosis and the expression of Fas and Fas-ligand antigen after orthotopic liver transplantation.
    Tannapfel A; Kohlhaw K; Schwarz R; Wenzke M; Köckerling F; Ebelt J; Hauss J; Wittekind C
    Transplant Proc; 1998 Aug; 30(5):2358-9. PubMed ID: 9723503
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of fas ligand in uveal melanoma-induced liver damage.
    Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen.
    Minagawa R; Okano S; Tomita Y; Shimizu I; Iwai T; Kishihara K; Nomoto K; Sugimachi K; Nomoto K
    Transplant Proc; 2001; 33(1-2):283. PubMed ID: 11266820
    [No Abstract]   [Full Text] [Related]  

  • 48. Fas system up-regulation in experimental autoimmune encephalomyelitis.
    Ouallet J; Baumann N; Marie Y; Villarroya H
    J Neurol Sci; 1999 Nov; 170(2):96-104. PubMed ID: 10561524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Ramadas R; Yeong ML; Benjamin CD; Hess D; Munn SR
    J Surg Res; 2003 Nov; 115(1):1-8. PubMed ID: 14572766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
    Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
    J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis.
    Guillot C; Coathalem H; Chetritt J; David A; Lowenstein P; Gilbert E; Tesson L; van Rooijen N; Cuturi MC; Soulillou JP; Anegon I
    J Immunol; 2001 Apr; 166(8):5225-35. PubMed ID: 11290807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
    Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
    J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
    Afford SC; Ahmed-Choudhury J; Randhawa S; Russell C; Youster J; Crosby HA; Eliopoulos A; Hubscher SG; Young LS; Adams DH
    FASEB J; 2001 Nov; 15(13):2345-54. PubMed ID: 11689460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis.
    Wigginton JM; Park JW; Gruys ME; Young HA; Jorcyk CL; Back TC; Brunda MJ; Strieter RM; Ward J; Green JE; Wiltrout RH
    J Immunol; 2001 Jan; 166(2):1156-68. PubMed ID: 11145697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The CD95/CD95L system as target for modulation of allogeneic immune responses].
    Schwinzer R; Dulat H; Kyas U; Wonigeit K
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):655-8. PubMed ID: 14518336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposome.
    Li XK; Okuyama T; Tamura A; Fujino M; Funeshima N; Kaneda Y; Kita Y; Enosawa S; Amemiya H; Suzuki S
    Transplant Proc; 1998 Jun; 30(4):943. PubMed ID: 9636379
    [No Abstract]   [Full Text] [Related]  

  • 58. Alleviation of ischemia-reperfusion injury in rat liver transplantation by induction of small interference RNA targeting Fas.
    Li X; Zhang JF; Lu MQ; Yang Y; Xu C; Li H; Wang GS; Cai CJ; Chen GH
    Langenbecks Arch Surg; 2007 May; 392(3):345-51. PubMed ID: 17235585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure.
    Ryo K; Kamogawa Y; Ikeda I; Yamauchi K; Yonehara S; Nagata S; Hayashi N
    Am J Gastroenterol; 2000 Aug; 95(8):2047-55. PubMed ID: 10950056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance.
    Li W; Carper K; Liang Y; Zheng XX; Kuhr CS; Reyes JD; Perkins DL; Thomson AW; Perkins JD
    Transplant Proc; 2006 Dec; 38(10):3207-8. PubMed ID: 17175224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.